Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience.
ANZ journal of surgery(2023)
摘要
This study confirms the clinical efficacy of cemiplimab in patients with advanced CSCC with many experiencing a durable response and an acceptable adverse effect profile.
更多查看译文
关键词
advanced cutaneous squamous cell carcinoma,cemiplimab,checkpoint inhibitors,efficacy,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要